基于 (II) 的工程纳米颗粒用于与多目标氧化还原催化作用的协同声动疗法
Jianing Chen1, Chaoyi Zhu2, Siqi Tang2
1Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Health Science Center, Ningbo University, China.
Bioorganic chemistry
|January 8, 2026
概括
这项研究引入了一种用于声敏剂的新型捐赠者工程策略,创建有针对性的纳米粒子,通过诱导细胞死亡和瘤回归来增强声动疗法 (SDT) 对结直肠癌的疗效.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术 纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 声动力疗法 (SDT) 通过克服光限制,比光动力疗法 (PDT) 具有优势.
- 目前的声敏化器设计优先考虑接受器工程,往往会损害生物相容性.
- 建议采用捐赠工程方法来提高声敏剂的性能和安全性.
研究的目的:
- 开发一种由捐赠者设计的新型声敏化剂,用于增强癌症治疗.
- 创建瘤向纳米颗粒,以提高药物输送和疗效.
- 研究开发的纳米平台在结直肠癌中的治疗效果和机制.
主要方法:
- 通过使用捐赠工程策略合成了一系列鲁II) 复合物 ([Ru(tpy) ((Aze-phen) Cl] ((PF6)).
- 通过使用DSPE-PEG2000的自组装来制造瘤向的纳米颗粒 (NanoRu).
- 在超声波照射下使用癌细胞系和CT26瘤模型在体外和体内评估NanoRu的疗效.
主要成果:
- 与类似物相比,捐赠者设计的复合物显示出明显更高的NADH声触媒氧化效率.
- 纳米Ru纳米颗粒有效地准线粒体和细胞核,诱导协同治疗效应.
- 在小鼠中观察到显著的瘤回归 (83%),以及铁亡,亡和DNA损伤的证据.
结论:
- 开发的基于Ru (II) 的平台代表了通过捐赠工程在声敏化器设计中的突破.
- 纳米Ru纳米颗粒显示出克服化学阻力和推进精确的声动力化学疗法的前景.
- 这种方法为开发用于癌症治疗的有效和生物相容的声敏化剂提供了新的策略.
更多相关视频
相关概念视频
01:46Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
02:17Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
3.8K
Catalytic hydrogenation of alkenes is a transition-metal catalyzed reduction of the double bond using molecular hydrogen to give alkanes. The mode of hydrogen addition follows syn stereochemistry.
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
3.8K